1-153974042-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000368607.8(CREB3L4):c.1165G>A(p.Val389Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,613,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000368607.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CREB3L4 | NM_001255978.2 | c.1165G>A | p.Val389Met | missense_variant | 10/10 | ENST00000368607.8 | NP_001242907.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CREB3L4 | ENST00000368607.8 | c.1165G>A | p.Val389Met | missense_variant | 10/10 | 1 | NM_001255978.2 | ENSP00000357596 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000187 AC: 47AN: 251086Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135740
GnomAD4 exome AF: 0.000150 AC: 219AN: 1461634Hom.: 0 Cov.: 31 AF XY: 0.000135 AC XY: 98AN XY: 727122
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 16, 2024 | The c.1165G>A (p.V389M) alteration is located in exon 10 (coding exon 9) of the CREB3L4 gene. This alteration results from a G to A substitution at nucleotide position 1165, causing the valine (V) at amino acid position 389 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at